AUPH FY 2021 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

AUPHAurinia Pharmaceuticals Inc.

$2B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$46M-9.0% YoY

Gross Profit

$45M97.6% margin

Operating Income

-$181M-396.3% margin

Net Income

-$181M-396.8% margin

EPS (Diluted)

$-1.40

Cash Flow

Operating Cash Flow

-$158M

Free Cash Flow

-$159M

Stock-Based Comp.

$31M

Balance Sheet

Total Assets

$543M

Total Liabilities

$64M

Stockholders' Equity

$479M

Cash & Equivalents

$232M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$46M	$50M	-9.0%
Gross Profit	$45M	$50M	-11.2%
Operating Income	-$181M	-$104M	-73.3%
Net Income	-$181M	-$103M	-76.2%